World's Best Scientists 2026 revealed!

Shraga Segal publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shraga Segal sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Shraga Segal D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shraga Segal sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

    R. Wallich;N. Bulbuc;G. J. Hämmerling;S. Katzav

  • Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.

    Michael Karas;Hadar Amir;Daniel Fishman;Michael Danilenko

  • CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells

    Xiaoping Song;Yakov Krelin;Tatyana Dvorkin;Olle Bjorkdahl

  • Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors

    Yakov Krelin;Elena Voronov;Shahar Dotan;Moshe Elkabets

  • Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour–host interactions

    Ron N. Apte;Yakov Krelin;Xiaoping Song;Shahar Dotan

  • Prophylactic and Therapeutic Efficacy of Human Intravenous Immunoglobulin in Treating West Nile Virus Infection in Mice

    David Ben-Nathan;Shlomo Lustig;Guy Tam;Shahar Robinzon

  • Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties

    Patrick De Baetselier;Shulamit Katzav;Eliezer Gorelik;Michael Feldman

  • Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.

    Xiaoping Song;Elena Voronov;Tatyana Dvorkin;Eyal Fima

  • MHC imbalance and metastatic spread in Lewis lung carcinoma clones

    Lea Eisenbach;Shraga Segal;Michael Feldman

  • The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

    Lea Eisenbach;Nurit Hollander;Lea Greenfeld;Hadas Yakor

  • Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor

    Mina Fogel;Eliezer Gorelik;Shraga Segal;Michael Feldman

  • Differences in Resistance of Metastatic Tumor Cells and Cells From Local Tumor Growth to Cytotoxicity of Natural Killer Cells

    Eliezer Gorelik;Mina Fogel;Michael Feldman;Shraga Segal

  • Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.

    E Tzehoval;S Segal;Y Stabinsky;M Fridkin

  • Defective induction of antigen‐reactive proliferating T cells in B cell‐deprived mice

    Yacov Ron;Patrick De Baetselier;Julius Gordon;Michael Feldman

  • Growth of a local tumor exerts a specific inhibitory effect on progression of lung metastases.

    Eliezer Gorelik;Shraga Segal;Michael Feldman

  • Thymus-Derived Lymphocytes: Humoral and Cellular Reactions Distinguished by Hydrocortisone

    Shraga Segal;Irun R. Cohen;Michael Feldman

  • Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.

    P De Baetselier;E Roos;L Brys;L Remels

  • Reduced tumorigenicity of fibrosarcomas which constitutively generate il‐1α either spontaneously or following il‐1α gene transfer

    Amos Douvdevani;Mahmoud Huleihel;Margot Zöller;Shraga Segal

  • Control of Lung Metastasis Progression in Mice: Role of Growth Kinetics of 3LL Lewis Lung Carcinoma and Host Immune Reactivity,

    E Gorelik;S P Segal;M I Feldman

  • IN VITRO INDUCTION OF A PRIMARY RESPONSE TO THE DINITROPHENYL DETERMINANT

    Shraga Segal;Amiela Globerson;Michael Feldman;Joseph Haimovich

Frequent Co-Authors

Michael Feldman
Michael Feldman Weizmann Institute of Science
Ron N. Apte
Ron N. Apte Ben-Gurion University of the Negev
Mahmoud Huleihel
Mahmoud Huleihel Ben-Gurion University of the Negev
Elena Voronov
Elena Voronov Ben-Gurion University of the Negev
Margot Zöller
Margot Zöller Heidelberg University
Günter J. Hämmerling
Günter J. Hämmerling German Cancer Research Center
Mati Fridkin
Mati Fridkin Weizmann Institute of Science
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
David Givol
David Givol Weizmann Institute of Science
Lars Björck
Lars Björck Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing a career in immunology within healthcare, several online degree options can provide a strong foundation. Many professionals start by earning a Bachelor of Science in Nursing (BSN), and the best online BSN programs for non nurses offer flexible pathways designed specifically for individuals without prior nursing experience.

Accelerated paths are also popular, allowing students to complete their nursing degrees more quickly than traditional routes. Programs recognized as the accelerated nursing programs provide viable options for fast-tracking education while balancing other commitments. Continuing education through accelerated nurse practitioner programs can further enhance qualifications and open doors to specialized roles in immunology research or clinical practice.

For nurses looking to specialize, achieving an acute care nurse practitioner certification is a valuable step. This credential equips healthcare professionals with advanced skills to manage critical patient care, closely aligning with immunology-related challenges in acute and complex cases. Exploring these educational and career pathways can help individuals align their immunology interests with rewarding healthcare roles.

Best Scientists Citing Shraga Segal

Recently Published Articles